Pfizer and Merck, ostensibly beleaguered drugmakers, have seen their shares battered despite reporting strong earnings.

CEO Albert Bourla says Pfizer has met the strategic goals it had set for itself in 2024, and that it was ‘executing ...

Pfizer CEO has met with the new administration and believes Trump and RFK Jr. are going to be net positives for the health ...

We recently compiled a list of the Jim Cramer Shed Light on These 9 Stocks. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against the other stocks Jim Cramer ...

The United States is seeing a second peak in flu cases this season. After doctor’s office visits for flu dipped early this ...

Related to Kennedy’s known hostility to pharmaceutical manufacturers is his criticism of vaccines — which was the primary focus of Democrats’ attacks on him. Their questions not only distorted his ...

Developers celebrate gains for advances with radiopharmaceuticals while regulators and isotope suppliers work to keep up.

The political analyst Yuval Levin discusses Trump’s first few weeks in office and the limits of presidential power.

In hearings Wednesday and Thursday, senators questioned President Trump's nominee for Secretary of Health and Human Services, ...

Q4 2024 Earnings Conference Call February 4, 2025 8:00 AM ETCompany ParticipantsSteve Winoker - Chief Investor ...

If the drug is approved by the US Food and Drug Administration for the treatment of acute pain in January as expected, the ...

Eight leaders from across the fields of agriculture were recognized with the Purdue Agricultural Alumni Association’s highest ...